Tenon Medical Regains Nasdaq Compliance Relating To Maintaining Shareholders' Equity Minimum Of $2.5M
Tenon Medical, Inc. TNON | 0.00 |
On July 17, 2026, the Company received a notice from Nasdaq that, based on the July 10 8-K (as defined below), the Company had regained compliance with the Stockholders' Equity Rule (as defined below). However, if the Company fails to evidence compliance upon filing its Quarterly Report on Form 10-Q for the period ending September 30, 2026, the Company may be subject to delisting, and any such delisting would be subject to appeal.
On July 10, 2026, the Company filed a Current Report on Form 8-K (the "July 10 8-K") that disclosed its belief that it satisfied Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Rule") as of such filing date due to the completion of its $4.2 million public offering of common stock and warrants on July 1, 2026.
